359880-05-0 Usage
Uses
Used in Pharmaceutical Industry:
N-Cyclobutyl-4-piperidone is used as a key intermediate in the production of various pharmaceuticals for its ability to contribute to the synthesis of biologically active molecules, enhancing the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, N-Cyclobutyl-4-piperidone serves as an intermediate in the synthesis of pesticides, playing a crucial role in creating compounds that protect crops and enhance agricultural productivity.
Used as a Solvent:
N-Cyclobutyl-4-piperidone is utilized as a solvent in numerous industrial processes due to its capacity to dissolve a variety of substances, facilitating chemical reactions and material processing.
Used as an Additive:
N-Cyclobutyl-4-piperidone also functions as an additive in different industries, where it can improve the performance characteristics of products, such as viscosity, stability, or reactivity, depending on the application requirements.
Check Digit Verification of cas no
The CAS Registry Mumber 359880-05-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,9,8,8 and 0 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 359880-05:
(8*3)+(7*5)+(6*9)+(5*8)+(4*8)+(3*0)+(2*0)+(1*5)=190
190 % 10 = 0
So 359880-05-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H15NO/c11-9-4-6-10(7-5-9)8-2-1-3-8/h8H,1-7H2
359880-05-0Relevant academic research and scientific papers
AZACYCLIC COMPOUNDS
-
Paragraph 0628; 0666, (2015/11/09)
Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
USE OF 4-AMINO-PIPERIDINES FOR TREATING SLEEP DISORDERS
-
Page/Page column 136, (2010/11/28)
Inverse agonists and antagonists of serotonin receptors are disclosed for use in treating sleep disorders such as insomnia, and specifically sleep maintenance insomnia. The compound increase slow wave sleep, decrease the number of awakenings after sleep onset, and decrease the time awake after sleep onset.
Azacyclic compounds
-
, (2008/06/13)
Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
